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Background. Subcategorising patients with chronic low back pain (CLBP) could improve patient outcomes and facilitate
prioritisation of treatment resources. Objective.This study aimed to develop a subcategorising method for individuals with CLBP
using the Coping Strategies Questionnaire 24 (CSQ24) and to investigate the methods potential validity.Methods. 196 patients were
recruited from a physiotherapy outpatients department. All participants completed a battery of questionnaires before and after
treatment including the CSQ24 and a measure of pain, disability, and mood. At discharge participants also completed a global
subjective outcomes scale consisting of a 6-point Likert scale. All participants received usual physiotherapy. Results. Cut-off values
for the CSQ24 were calculated using triangulation of the findings from three different statistical methods. Cut-off values were
identified for the Catastrophising and Cognitive Coping subscales of the CSQ24. Participants were categorised into low, medium,
and high risk of a poor outcome.The cut-off values for these were ≥21 on Cognitive Coping and ≤9 on Catastrophising for low risk
and ≤15 on Cognitive Coping for high risk, with all other patients being classified as being at moderate risk. Conclusion. Further
validation is required before this approach can be recommended for clinical practice.
1. Introduction
Back pain constitutes a significant health problem, with a
lifetime prevalence of 80–85% [1]. Despite this, our under-
standing of the condition remains relatively poor and it has
been said that “For one of the most common and debilitating
conditions we have no real answers” [2]. Exercise based
therapy combined with adjunctive treatment such as manip-
ulations or acupuncture delivered within a psychosocially
aware environment can be beneficial for many patients [3, 4].
However, a significant number of patients continue to have
variable longer term outcomes from treatment and between
42% and 75% continue to suffer some degree of back pain a
year after its first onset [3].
One potential theory for the lack of consistent treatment
success may be attributable to the fact that patients with
nonspecific low back pain (LBP) have been consideredwithin
the literature as a homogenous group [5]. It is hypothesised
however that within the broad diagnostic category of non-
specific mechanical low back pain there are a number of
subgroups which could respond well to specifically tailored
interventions.
This theory is dependent on the idea that LBP patients
can be subcategorised intomore homogenous subgroups and,
following this, treatments that best suit each group can be
developed and tested. There is growing interest into which
constructs or sets of constructs might be most appropriate to
categorise patients into subgroups [6–8]. One of the earliest
subgrouping methods for LBP, the McKenzie method, was
proposed by McKenzie and May in 2003 [9]. The McKenzie
method subgrouped patients into three broad categories:
postural syndrome, dysfunctional syndrome, or derangement
syndrome, based upon their pain response to movements
in different directions during assessment [9]. Though still
commonly used in clinical practice, there is limited evidence
for the effectiveness of this classification system [10].
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A more recent movement-based subgrouping system
proposes thatmaladaptivemotor behaviour exposes the spine
to on-going strain resulting in pain [11].The system combines
a patho-/anatomical and psychosocial approach for diagnosis
and management. The system proposes five directional sub-
groups of which flexion pattern and active extension pattern
are the most common ones [11]. While there is growing
evidence around the validity and reliability of this approach
for sub classification [12–14], there remains little evidence of
its clinical effectiveness in prospective intervention studies.
Over the last five years the STarT back screening tool
(SBT) has shownpromising results as a potential subgrouping
tool [15, 16].The SBT usesmultidimensional variables includ-
ing pain, disability, and psychosocial constructs to categorise
patients as low, medium, or high risk of a poor outcome [15].
Results from a recent randomised controlled trial, which used
this subgrouping protocol to inform a subsequent pathway
of care, have been promising. Patients who received stratified
care informed by the STarT back protocol had improved and
had more cost effective outcomes at 12 months [16].
A number of predominantly psychosocial variables [6–
8, 11, 17, 18] have been shown to have a relationship with
poor outcome and/or work loss in chronic back pain. The
majority of such studies however exclude analysis or findings
that allow useful application of results to clinical practice.
This is because such studies often fail on two issues: (1) to
identify and validate subgrouping cut-off points within the
tools examined and (2) to test the clinical benefit of targeting
tailored treatment to these subgroups in prospective RCTs.
The STarT program [16] is one of the few instances where
these two issues have been addressed. The issue remains
however that many studies, including STarT back, use mixed
sets of constructs, such as pain, disability, and a range of
psychosocial or quality of life variables to subgroup patients
with LBP. While using a mixture of variables has shown
some efficacy, it does not help identify which constructs are
most useful for subcategorisation purposes. As a result it is
possible some variables used in categorisation tools may be
redundant. Identifying and examining a specific construct,
such as coping, and establishing its specific subcategorisation
properties would help start addressing this issue.
Investigation to discover the relative value of specific
constructs like pain, disability or coping to subcategorise
patients may also facilitate the development of more specif-
ically tailored treatment programs to address the particular
issues associated with that construct. If specific constructs
within coping linked to poor outcome could be identified,
for instance, then a treatment approach to address that
specific construct could be designed and prospectively tested.
Multidimensional categorisation tools, though having some
efficacy, do not facilitate the development and testing of
novel treatment approaches. If the value of a single construct,
such as coping, in categorising patients can be identified,
then novel approaches aimed specifically at addressing issues
related to the fact that construct could be tested.
The aim of this study was therefore to (1) develop a
high, medium, and low risk based subcategorising protocol
for patients with LBP using the constructs measured by the
Coping Strategies Questionnaire 24 (CSQ24) [19] and (2)
investigate the potential validity of the protocol developed to
inform future study.
The CSQ24 [19] was chosen as the tool to be evaluated
as it is recommended for use [20] over the original CSQ [21]
which remains one of the longest standing and frequently
researched coping tools internationally [22]. As clinical use of
categorisation methods and subsequently stratified care also
require repeated testing, the tool used also needs to prove
longitudinal validity and this has recently been established
for the CSQ24 [23]. It is also often noted that fear, as
measured by Catastrophising within the CSQ and CSQ24,
explains a greater proportion of variance in disability in
back pain than do many other constructs [24]. Further than
this, however, conceptually the CSQ24 has an advantage
over other commonly used tools in the field, like the fear
avoidance beliefs questionnaire (FABQ) [25], as, in addition
to measuring the presence of negative constructs such as fear,
it is the only tool of its kind thatmeasures a positive construct,
in this case Cognitive Coping. As the absence of a negative
construct does not necessarilymean the presence of a positive
construct and when identification of patients at the lowest
risk of poor outcome is a goal, a tool identifying both negative
and positive constructs is at least conceptually advantageous.
2. Methods
2.1. Inclusion Criteria. Patients were recruited from a sample
completing physiotherapy treatment after referral from a
back pain assessment clinic. Participants were included if
they were aged 16–85 years and had chronic low back pain
[CLBP] (with or without leg pain) for ≥3 months of duration.
Individuals were excluded from the study if they had any red
flags indicating serious pathology, if they had any medical
condition that would contraindicate physiotherapy treatment
or if they lacked the capacity to give informed consent.
2.2. Procedure. Participants recruited into the study com-
pleted a battery of questionnaires before and after physio-
therapy treatment. The battery of questionnaires included
the Coping Strategies Questionnaire 24 (CSQ24) [19], a pain
visual analogue scale (VAS) [26], The Roland and Morris
disability questionnaire 18 (RMDQ-18) [27], and the Hospital
Anxiety and Depression (HAD) scale [28]. At discharge
patients also completed a global subjective outcomes scale
consisting of a 6-point Likert scale with response points
labelled from “I Feel Worse” to “Completely Better.” A range
of participant demographic information was also recorded
including age, gender, duration of symptoms, and comor-
bidities. Participants received usual care physiotherapy. The
number and type of treatments provided to each participant
were recorded in addition to total length of time under
treatment.
2.3. Materials. Participant coping was assessed using the
CSQ24. The CSQ24 [19] is a shortened version of the Coping
Strategies Questionnaire (CSQ) [20] recommended for use
over the original version [28]. The CSQ24 consists of 23
items about coping, with a 7-point Likert scale anchored
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with “Never Do That” and “Always Do That,” and one item
measuring perceived control over pain with a 7-point Likert
scale is anchored with “No Control” and “Complete Control.”
The CSQ24 has four subscales: Catastrophising, Diverting
Attention, Reinterpreting, and Cognitive Coping; each sub-
scale is scored from 0 to 36. The CSQ24 has demonstrated a
good level of validity as a measure of coping in individuals
with CLBP [19, 23].
Pain was assessed using a VAS anchored with “No pain”
and “Worst Possible Pain” and referring to “average pain
over the last week.” The VAS is a valid and reliable measure
of pain [25]. Function was measured using the RM-18, a
commonly used back pain specific questionnaire consisting
of 18 “yes” or “no” items. A higher score suggests poorer levels
of functioning. The questionnaire has demonstrated good
levels of validity as a measure of physical function in patients
with CLBP [27].
The Hospital Anxiety and Depression (HAD) scale has
been used to assess participants’ levels of anxiety and depres-
sion. The scale consists of 14 items measured on a 4-point
Likert scale with varying anchoring statements. The scale is
scored from0 to 21 for both anxiety anddepressionwith lower
scores indicating less presence of the construct. The scale has
been noted to be valid and reliable for individuals with CLBP
[28].
At discharge, participants completed a global subjec-
tive outcomes (GSO) scale consisting of a 6-point Likert
scale with response points labelled from “I Feel Worse” to
“Completely Better.” Such scales are valid for use in clinical
settings [29] and are seen as the “gold standard” for use when
establishing clinically significant change, and subsequently
they represent a highly relevant anchor variable when linking
clinical assessment scores to outcomes in subcategorisation
studies [30, 31].
2.4. Analysis. Establishing multiple valid cut-off points using
a psychosocial variable to establish risk of poor outcome is
difficult. No gold standard protocol exists, and frequently
employed methods of establishing a single cut-off point
such as using receiver operating characteristic (ROC) curve
analysis only output a binary categorisation so cannot be
used. As an alternative to ROC curve analysis in the estab-
lishment of clinically important change, indices using mean
scores anchored to establish outcome indicators such as
global subjective outcome can be used. This method has
been employed in articles used to establish an international
consensus regarding pain measurement [32]. This method
also seems valid in this case where multiple screening cut off
points are needed.
Tomaximise validity a triangulation approach using three
different but complementarymethodswas chosen to establish
the cut-off point for patients at high, medium, and low
risk of poor outcome using the CSQ24. The findings from
these three methods were compared to identify the most
appropriate cut-off values to subcategorise the participants.
Only the Catastrophising and Cognitive Coping subscales
were used to establish cut-off scores, as a large sample
study suggests that most respondents tend to score highly
on either Cognitive Coping or Catastrophising [33], with
few respondents scoring highly on more than one subscale
concurrently. Evidence also suggests that Reinterpreting may
have poor construct validity and Diversion scores remain
difficult to be interpreted regarding their positive or negative
effect on the individual [19].
2.4.1. Method One. The first method was based upon the
suggestion byHarland andGeorgieff [19] that, as themajority
of respondents will have some degree of positive score on
each of the CSQ24’s four constructs, the construct attracting
the highest score should be seen as that individuals’ domi-
nant coping strategy. With Catastrophising being seen as a
negative marker of outcome [34–36] and Cognitive Coping
being seen as a positive marker [37–39] the average score
for Catastrophising and Cognitive Coping was calculated
after examining the cases at baseline assessment, according
to dominant coping strategy (Cognitive Coping or Catas-
trophising) at the time.
2.4.2. Method Two. The second method calculated the aver-
age assessment score for both Cognitive Coping and Catas-
trophising for those patients that, at discharge, were either “a
lot better” or “completely better” using the GSO scale. This
would provide figures that could be used to identify those
patients at the least risk of poor outcome. When definitive
identification of cases at the least risk of poor outcome was
needed and when evidence shows that many patients who
successfully complete treatment continue to have pain to
some degree for a year or more afterwards [3], it was not
felt valid to include the “moderately better” outcomes in this
method.
2.4.3. Method Three. The third method used HAD scores as
an anchor to relate to mean Catastrophising and Cognitive
Coping scores as anxiety and depression have significant
correlations with multiple other back pain measures [40–
44]. The data was split according to an established cut-
off point of 12 or more for anxiety or depression, this cut
off identifying patients likely to be negatively affected and
therefore potentially more difficult to treat [45]. Data from
the study was examined and the average Catastrophising
and Cognitive Coping score was calculated for participants
according towhether they scored 12 ormore on either anxiety
or depression using the HAD.
3. Results
3.1. Participant Characteristics. 196 cases were recruited into
the study. The average age of participants was 52 years (SD
14.59) and 42% (𝑛 = 81) of participants were male. 13%
(𝑛 = 26) of participants were not working due to their back
pain and 41% (𝑛 = 80) had had back pain for over 10 years.
The treatment received by participants was predominantly
exercise based (89% of cases) and patients received between
2–4 treatments over a period of ∼11 weeks. Treatment was not
controlled to ensure that results remain relevant to normal
clinical situations.
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3.2. Method 1. When the average Catastrophising and Cog-
nitive Coping score is calculated regarding individuals who
scored most highly on the Catastrophising scale at assess-
ment, theoretically therefore being at greater risk of poor
outcome (12.8% of participants, 𝑛 = 24), the scores are 23.29
and 12.79, respectively. Individuals scoring more highly than
23 on Catastrophising and less than 13 on Cognitive Coping
at assessment could therefore potentially be seen as being at
higher risk of poor outcome.
When the average Catastrophising and Cognitive Coping
score is calculated regarding individuals who scored most
highly on the Cognitive Coping scale at assessment, theoret-
ically therefore being at lower risk of poor outcome (65.2%
of participants 𝑛 = 124), the scores are 7.16 and 23.66,
respectively. In this case a score of 7 or less onCatastrophising
and of 24 or more on Cognitive Coping could be used.
Pragmatically these cut-off scores have little value when the
more simple method of using the dominant coping strategy
at the time can be used, but, in this case, when triangulation
around proposed scores is being attempted, they represent a
theoretically sound base line.
3.3.Method 2. Theaverage scores for those shown to be at low
risk of poor outcome, reporting to be “a lot better” (𝑛 = 121,
61.7%) or “completely better” (𝑛 = 9, 4.6%) at discharge were
20.37 for Cognitive Coping and 9.84 for Catastrophising.The
method of using global subjective outcome as an anchor to
link coping scores was of limited use in identifying potential
cut-off scores for patients at high risk of poor outcome.
This was due to no patients reporting to be worse and only
(𝑛 = 6, 3.1%) reporting to be the same at discharge from
physiotherapy treatment.
This study recruited patients completing physiotherapy
care rather than those unable to complete care and sub-
sequently referred on for further opinion, such as from a
surgeon. As a result, data was not gained from this groupwho
may have shown unchanged or worsening clinical outcome
scores. As outlined in the method section, it was not felt that
scores from those reporting to be “moderately better” (𝑛 = 43,
21.9%) were definitive enough to be used in the production
of a low risk of poor outcome category. The lack of data
regarding unchanged or worsening patients is a limitation of
this study.
3.4. Method 3. The cut-off values calculated for the CSQ24
using method 3 are shown in Table 1. For Catastrophising
the mean difference between those scoring ≥12 or <12 was
significantly different (𝑃 = .000) for both anxiety and
depression, respectively, using an independent samples 𝑡-test.
In the case of Cognitive Coping the mean difference between
those scoring ≥12 or <12 for anxiety and depression was also
significantly different (𝑃 = .004 and 𝑃 = .000), respectively.
This provides evidence of a statistically significant difference
between these populations. The figures would suggest that
a score of 20 or more on the Catastrophising scale, with
this being a pragmatic number between the scores of 19.25
and 21.07 for anxiety and depression, respectively, could
potentially be used as cut-off value for patients at high risk of
Table 1: Cut-off values for the Catastrophising and Cognitive
Coping scores of the CSQ24 using method 3.
Anxiety Depression
≥12 <12 ≥12 <12
(𝑛 = 20) (𝑛 = 168) (𝑛 = 15) (𝑛 = 173)
Coping (range
0–21) 16.25 (6.23) 21.48 (7.61) 14.40 (7.15) 21.49 (7.43)
Catastrophising
(range 0–21) 19.25 (7.73) 9.33 (7.43) 21.07 (8.63) 9.46 (7.32)
Cut-off values are the mean scores for the Coping and Catastrophising
subscale of the CSQ24 calculated from published cut-off values for the HAD
scale. Data are presented as mean (1SD).
poor outcome. A score of 15 or less on the Cognitive Coping
scale could potentially be used for similar purposes.
Using the same strategy of examiningmean scores of data
split according to significant anxiety or depression, a cut-off
score regarding Catastrophising and Cognitive Coping can
also be established to identify patients potentially at least
risk of poor outcome. In this case, as shown in Table 1, a
score of 21 or more on Cognitive Coping or of 9 or less on
the Catastrophising scale could potentially be used for this
purpose.
3.5. Triangulation of Methods. The cut-off values for the
three methods used are shown in Table 2. The three different
analysis methods used to indicate possible CSQ24 cut-off
scores produced broadly similar scores.
Using the results from method 3 that produced the
median values for the different methods, figures of ≥21 on
Cognitive Coping and ≤9 on Catastrophising could be used
to identify low risk patients and figures of ≤15 on Cognitive
Coping and ≥20 on Catastrophising could be used to identify
high risk patients. The data was then examined to identify
what proportion of cases would subsequently fall into each
category if the protocol was applied to the study population.
If individuals had to meet both Catastrophising and
Cognitive Coping cut-off scores to be categorised as high
or low risk, 27% of patients would fall into the low risk
category and 17% into the high risk category, leaving 56% in
the moderate risk category.
4. Discussion
The aim of this study was to develop a method for subcate-
gorising individuals with CLBP according to high, medium,
or low risk of poor outcome using only the construct
of coping as the subcategorising variable. In this way, in
the developing field of subcategorisation and subsequently
stratified care, the value of coping can be assessed and future
studies are planned to test the protocol prospectively or
compare figures with the outcome of other protocols.
Epidemiology figures suggest that a proportion of back
pain patients are not improved significantly with treatment
and/or continue to suffer disability in the long term [3].
It seems that, although patients may report improvement
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Table 2: Identified cut-off values for the CSQ24 using three different
methods.
Risk Catastrophising Cognitive Coping
High Medium Low High Medium Low
Method 1 ≥23 8–22 ≤7 ≥13 14–23 ≥24
Method 2 NA NA ≤10 NA NA ≥20
Method 3 ≥20 10–19 ≤9 ≤15 16–20 ≥21
Suggested scores ≥20 10–19 ≤9 ≤15 16–20 ≥21
All scores are measured in a range from 0 to 36.
with physiotherapy or other care, that improvement may
only be partial or temporary, and these cases continue to
utilise health resources and report both pain and disability, as
such, within this context, patients who may report a degree
of improvement but present with risk factors such as high
Catastrophising, anxiety, or depression may be at greater risk
of on-going symptoms. The potential to identify these cases
and tailor care accordingly to potentially improve the degree
and longevity of outcome is appealing.
Cut-off values have been derived from the Catastrophis-
ing and Cognitive Coping subscales of the CSQ24.This study
provides evidence to suggest that back pain patients able
to complete a course of physiotherapy care may be able to
be categorised into low, medium, or high risk of a poorer
overall outcome, using the scores suggested in Table 2. The
three methods used to identify appropriate cut-off points for
subcategorisation all produced broadly similar values adding
confidence to the validity of the values identified. It is a point
of strength of the study that a triangulation method was used
successfully. In theory the cut-off values identified could be
used to subcategorise patients for treatment purposes, though
further validation is required before the categorisation pro-
cess can be recommended for clinical practice.
According to the categorisationmethod used in this study
27% of patients were at low risk, 56% were at moderate risk
and 17% were at high risk of a poor outcome. These findings
are remarkably consistent with data from a study using
the STarT tool applied to a similar physiotherapy patient
population where 33% were categorised as low risk, 48% as
medium risk, and 19% as high risk [46]. It is encouraging that
the percentages found in this study are similar to those found
by Fritz et al. [46], and this adds significant evidence of the
potential validity of the values identified and provides some
assurance that the limitations of the sample, only being those
completing physiotherapy, have not led to significant skewing
of the data gained.
Despite the similarities found with Fritz et al. [46] assess-
ment of the percentage of patients that would fall into each
category led to questioning whether both Catastrophising
and Cognitive Coping criteria would need to be met in
order to categorise patients. Certainly with knowledge of
the relatively high number of CLBP patients who fail to
improve significantly with treatment and/or have on-going
pain, 17% did not seem to represent a realistic number of
those at high risk. A further analysis was therefore performed
to establish the percentage that would be gained if only the
Catastrophising orCognitiveCoping cut-off pointswere used
to categorise high risk patients. Under these terms, 13.5% and
25.5%, using the Catastrophising and Cognitive Coping cut-
off points, respectively, would fall into a high risk group.
When the nature of Cognitive Coping and Catastrophis-
ing is examined from a change perspective, Cognitive Coping
has been shown to be resistant to change over a period of
effective treatment, whereas Catastrophising has been shown
to be variable in nature over time [23]. Taking these factors
into account with Cognitive Coping apparently difficult
to change with treatment and stable over time, therefore
defining the patient more reliably than Catastrophising from
a screening perspective, it is suggested that only Cognitive
Coping is used to categorise patients into a high risk group.
Both Catastrophising and Cognitive Coping score cut-offs
could still be used to categorise into the low risk group.
The recommended protocol for categorising patients
according to risk of poor outcome using the CSQ24 is shown
as follows and in the study population would lead to 25.5%
being high risk, 27% being at low risk, and 47.5% being at
moderate risk of poor outcome.
high risk: Cognitive Coping ≤15,
low risk: Cognitive Coping ≥21 and Catastrophising
≤9,
moderate risk: all cases not falling into high or low
risk groups.
4.1. Limitations. A key limitation to the study is that no
patients reported being worse and only six reported being
the same at discharge from physiotherapy treatment. Patients
receiving conservative management who worsened signifi-
cantly would normally be referred on for alternative opinion
and were not recruited into the study.The results of this study
are therefore only applicable to a population of patients with
manageable pathology who are able to complete a course of
physiotherapy care.
4.2. Conclusions. This study provides evidence to suggest that
back pain patients able to complete a course of physiotherapy
care may be able to be categorized into low, medium, or high
risk of a poorer overall outcome. Although the cut-off values
can be used to subcategorize patients for treatment purposes,
further validations are required before the categorization
process can be recommended as a standard for clinical
practice.
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